Description
Discontinuation of imatinib in Belgian patients with chronic myeloid leukaemia
Article: Discontinuation of imatinib in Belgian patients with chronic myeloid leukaemia
€3.03
Related products
-
Article: Highlights in urologic cancer
€3.03 Add to cart -
Article: Clinically meaningful survival benefit with atezolizumab + nab-paclitaxel in previously untreated patients with PD-L1+ metastatic triple negative breast cancer
€3.03 Add to cart -
Article: Highlights in urologic cancer
€3.03 Add to cart -
Article: Highlights in respiratory oncology
€3.03 Add to cart
Reviews
There are no reviews yet.